CC
Schedule 13G filing
Coastlands Capital LP disclosed a 5.7% stake in KLRS
Coastlands Capital LP reported owning 5.7% of Kalaris Therapeutics, Inc. (KLRS) (1,355,119 shares) in a Schedule 13G filed Oct 26, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 26, 2026
- Source
- Schedule 13G
More KLRS insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.